1
TÍTULO: Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
AUTORES: Bellini, Angela; Poetschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clement, Nathalie; Combaret, Valerie; de Mora, Jaime Font; George, Sally L.; Jimenez, Irene; Jeison, Marta; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Morini, Martina; Muehlethaler Mottet, Annick; Noguera, Rosa; Pierron, Gaelle; Rossing, Maria; Taschner Mandl, Sabine; Van Roy, Nadine; Vicha, Ales; Chesler, Louis; Balwierz, Walentyna; Castel, Victoria; Elliott, Martin; Kogner, Per; Laureys, Genevieve; Luksch, Roberto; Malis, Josef; Popovic Beck, Maja; Ash, Shifra; Delattre, Olivier; Valteau Couanet, Dominique; Tweddle, Deborah A.; Ladenstein, Ruth; Schleiermacher, Gudrun; ...Mais
PUBLICAÇÃO: 2021, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, NÚMERO: 30
INDEXADO EM: WOS